Lisa D. Eli

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

Damage-induced phosphorylation of Sld3 is important to block late origin firing

Jaime López-Mosqueda, Nancy L. Maas, Zophonı́as O. Jónsson et al. · Nature · 2010 · 191 citations

Signal Transduction, Damage-induced Phosphorylation, Signaling Pathway +10

Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i> -Mutant Metastatic Breast Cancer

Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won et al. · Cancer Discovery · 2019 · 108 citations · Full text

A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue

Yining Shi, Weidong Huang, Yuping Tan et al. · Diagnostic Molecular Pathology · 2009 · 89 citations

Breast Oncology, Molecular Biology, Pathology +22

Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers

Joan T. Garrett, Cammie R. Sutton, Richard Kurupi et al. · Cancer Research · 2013 · 87 citations · Full text